BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Figure out How to Put resources into Lab Precious stones - 2The Longest Underwater Tunnel Connecting Germany and Denmark
- 3West Antarctica’s history of rapid melting foretells sudden shifts in continent’s ‘catastrophic’ geology
- 4Web designers for Independent ventures
- 5The Electric Bicycle Americans Can Confide in 2024
- Golan resident convicted of spying for Iran after passing tank movement, missile-impact data
- Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
- Some are walking out. Some are shouting. Some are oblivious. How kids are reacting to THAT 'Wicked: For Good' scene
- France honors the victims of the Paris attacks' night of terror 10 years on
- Eight Muslim nations condemn Israel's 'dangerous' new death penalty law
- The 25 Most Notable Style Crossroads in History
- It's been 20 years since MTV's golden couple split. These producers saw it all unravel.
- Hitting the brakes: Hubble Space Telescope watches doomed comet reverse its spin
- 6 Web-based Lawful Administrations: Extensive Surveys and Elements
